Stay updated on HepTcell Immunotherapy in Inactive CHB Clinical Trial
Sign up to get notified when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.

Latest updates to the HepTcell Immunotherapy in Inactive CHB Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. No substantive study content or navigation changes were observed.SummaryDifference0.0%

- Check19 days agoChange DetectedAdministrative revision update from v3.4.0 to v3.4.1; this does not affect study data or user interactions (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now shows Results First Posted and Last Update Posted as exact timestamps, replacing the previously shown Estimated versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision notice updated from v3.3.3 to v3.3.4; no trial details, eligibility criteria, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedThe Locations section is updated to add regional entries (California, Alberta, Ontario, Missouri, Oklahoma) and remove the separate location groupings, with the revision updated to v3.3.3.SummaryDifference0.6%

- Check76 days agoChange DetectedResults-related updates were added, including 'Results First Posted (Estimated)' on 2025-12-04 and associated results submission milestones. New and updated outcomes are listed, such as virologic response, serologic clearance of HBsAg and HBV DNA on Day 169, and changes in HBV markers and immune responses.SummaryDifference2%

Stay in the know with updates to HepTcell Immunotherapy in Inactive CHB Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HepTcell Immunotherapy in Inactive CHB Clinical Trial page.